West China Hospital
Clinical trials sponsored by West China Hospital, explained in plain language.
-
New mRNA vaccine aims to boost immunotherapy in Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests a new mRNA vaccine that targets a protein called FAP found in cancer-supporting cells. The goal is to help the immune system fight advanced solid tumors like lung, colorectal, or pancreatic cancer. Ten adults who have not responded to standard treatme…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New drug duo aims to shrink esophageal tumors before surgery
Disease control Not yet recruitingThis study tests whether giving two drugs—camrelizumab (an immunotherapy) and palbociclib (a targeted therapy)—before surgery can safely shrink tumors in people with esophageal cancer that can be removed. About 41 adults with resectable esophageal squamous cell carcinoma will rec…
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New stent technique aims to prevent deadly bleeding in liver disease patients
Disease control Not yet recruitingThis study tests a new way to use a stent (a small tube) in the liver to lower blood pressure and prevent dangerous bleeding from enlarged veins in people with cirrhosis. The new method uses a smaller balloon to open the stent, which may reduce side effects like confusion. About …
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Robotic surgery over 5G could bring expert care to remote High-Altitude regions
Disease control Not yet recruitingThis early-phase study will test whether surgeons in a city can safely operate a robot to remove liver parasites in patients located over 1,500 km away in high-altitude Tibet. Ten adults with liver echinococcosis (a parasitic infection) will have their surgery performed remotely …
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New hope for tough pancreatic cancer: combo therapy enters early human testing
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs, JDB153 and serplulimab, can safely shrink tumors in people with advanced pancreatic cancer that has stopped responding to standard treatments. Ten participants aged 18-75 will receive the combination and be monitored for s…
Phase: PHASE1, PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 19, 2026 11:49 UTC
-
Smart wearables could replace clinic visits for knee rehab
Symptom relief Not yet recruitingThis study looks at whether using a smart wearable device for remote rehabilitation is as good as going to the clinic for physical therapy after knee surgery for a discoid meniscus. Sixty people who had arthroscopic knee surgery will be split into two groups: one does rehab at ho…
Phase: NA • Sponsor: West China Hospital • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC